Skip to main content
SpringerLink
Log in

Mild Cognitive Impairment

  • Klinische Les
  • Published:
Huisarts en wetenschap Aims and scope

Samenvatting

Verwoerd JH, Mattace-Raso FUS. Mild Cognitive Impairment. Huisarts Wet 2012;55(10):464-7.

Mild Cognitive Impairment (MCI) is een heterogeen ziektebeeld dat geriaters en neurologen de laatste jaren geregeld diagnosticeren en waarnaar men veel onderzoek doet. MCI betreft een lichte cognitieve achteruitgang die erger is dan men op basis van leeftijd mag verwachten, maar die niet aan de diagnose dementie voldoet. Men stelt de diagnose op basis van anamnese en heteroanamnese, bij voorkeur aangevuld met een objectieve test om de cognitieve status in kaart te brengen. MCI is een belangrijke risicofactor voor het ontwikkelen van dementie; jaarlijks krijgt 5-15% van de patiënten met MCI dementie. Er zijn geen therapeutische opties voor MCI. Wel is het belangrijk eventuele somatische factoren te behandelen. Vooralsnog lijkt het vooral voor de huisarts belangrijk om de achtergrond van een gediagnosticeerde MCI of aangegeven lichte cognitieve problemen te kennen, en patiënten en hun naasten te begeleiden. Het stellen van de diagnose MCI door de huisarts zelf lijkt hierbij geen meerwaarde te hebben.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Petersen RC. Clinical practice. Mild cognitive impairment. NEJM 2011;364:2227–34.

    Article  PubMed  CAS  Google Scholar 

  2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8.

    Article  PubMed  CAS  Google Scholar 

  3. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42.

    Article  PubMed  CAS  Google Scholar 

  4. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–6.

    Article  PubMed  CAS  Google Scholar 

  5. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94.

    Article  PubMed  CAS  Google Scholar 

  6. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.

    Article  PubMed  CAS  Google Scholar 

  7. Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–20.

    PubMed  Google Scholar 

  8. Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164–6; discussion 1167.

    Google Scholar 

  9. Whitehouse P, Brodaty H. Mild cognitive impairment. Lancet 2006;367:1979.

    Article  PubMed  Google Scholar 

  10. Whitehouse PJ. Mild cognitive impairment - a confused concept? Nat Clin Pract Neurol 2007;3:62–3.

    Article  PubMed  Google Scholar 

  11. Maggini M, Vanacore N, Raschetti R. Cholinesterase inhibitors: drugs look ing for a disease? PLoS Med 2006;3:e140.

    Article  PubMed  Google Scholar 

  12. Ganguli M, Blacker D, Blazer DG, Grant I, Jeste DV, Paulsen JS, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011;19:205–10.

    Article  PubMed  Google Scholar 

  13. Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement 2012;8:14–21.

    Article  PubMed  Google Scholar 

  14. Moll van Charante E, Perry M, Vernooij-Dassen MJFJ, Boswijk DFR, Stoffels J, Achthoven L, et al. NHG-Standaard Dementie (derde herziening). Huisarts Wet 2012;55:306–17.

    Google Scholar 

  15. Mitchell AJ. A meta-analysis of the accuracy of the Mini-Mental State Exam ination in the detection of dementia and mild cognitive impairment. J Psychiatr Res 2009;43:411–31.

    Article  PubMed  Google Scholar 

  16. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9.

    Article  PubMed  Google Scholar 

  17. Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 2003;60:1777–81.

    Article  PubMed  Google Scholar 

  18. Freitas S, Simões MR, Alves L, Santana I. Montreal Cognitive Assessment: Validation Study for Mild Cognitive Impairment and Alzheimer Disease. Alzheimer Dis Assoc Disord 2011 Dec 20 [Epub ahead of print].

  19. Muangpaisan W, Petcharat C, Srinonprasert V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a ger iatric clinic. Geriatr Gerontol Int 2012;12:59–64.

    Article  PubMed  Google Scholar 

  20. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252–65.

    Article  PubMed  CAS  Google Scholar 

  21. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Int Med 2008;148:427–34.

    PubMed  Google Scholar 

  22. Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009;66:1151–7.

    Article  PubMed  Google Scholar 

  23. Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008;63:494–506.

    Article  PubMed  Google Scholar 

  24. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008;56:1424–33.

    Article  PubMed  Google Scholar 

  25. Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry 2008;79:1386–91.

    Article  PubMed  CAS  Google Scholar 

  26. Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007;64:1443–50.

    Article  PubMed  Google Scholar 

  27. Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007;68:1588–95.

    Article  PubMed  CAS  Google Scholar 

  28. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201–7.

    Article  PubMed  Google Scholar 

  29. Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006;66:828–32.

    Article  PubMed  CAS  Google Scholar 

  30. Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, et al. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231–8.

    Article  PubMed  Google Scholar 

  31. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007;68:1909–16.

    Article  PubMed  Google Scholar 

  32. Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:1485–91.

    Article  PubMed  CAS  Google Scholar 

  33. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;CD004514.

  34. Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2006;CD001747.

  35. Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008;CD002854.

  36. Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006;CD006104.

  37. Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognitionbased interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011;CD006220.

  38. Joosten-Weyn Banningh LW, Prins JB, Vernooij-Dassen MJ, Wijnen HH, Olde Rikkert MG, Kessels RP. Group therapy for patients with mild cognitive impairment and their significant others: results of a waiting-list controlled trial. Gerontology 2011;57:444–54.

    PubMed  Google Scholar 

  39. Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 2011;86:876–84.

    Article  PubMed  Google Scholar 

  40. Lautenschlager NT, Cox KL, Flicker L, Foster JK, Van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027–37.

    Article  PubMed  CAS  Google Scholar 

  41. Jansen APD, Van Hout HPJ, Nijpels G, Rijmen F, Dröes RM, Pot AM, et al. Casemanagement bij beginnende dementie. Huisarts Wet 2011;55:58–63.

    Article  Google Scholar 

  42. Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008;178:1273–85.

    Article  PubMed  Google Scholar 

  43. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455–9.

    Google Scholar 

  44. Iliffe S, Manthorpe J, Eden A. Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. Fam Pract 2003;20:376–81.

    Article  PubMed  Google Scholar 

  45. Joosten-Weyn Banningh L, Vernooij-Dassen M, Rikkert MO, Teunisse JP. Mild cognitive impairment: coping with an uncertain label. Int J Geriatr Psychiatry 2008;23:148–54.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. afdeling Huisartsgeneeskunde, Erasmus MC, 3000 CA, Rotterdam, The Netherlands

    J. H. Verwoerd &  F. U. S. Mattace-Raso

Authors
  1. J. H. Verwoerd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. U. S. Mattace-Raso
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

arts in opleiding tot huisarts en onderzoeker.

klinisch geriater, universitair docent

Mogelijke belangenverstrengeling: niets aangegeven.

About this article

Cite this article

Verwoerd, J.H., Mattace-Raso, F.U.S. Mild Cognitive Impairment. HUISARTS WETENSCHAP 55, 464–467 (2012). https://doi.org/10.1007/s12445-012-0228-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12445-012-0228-y

Search

Navigation